Table 3 Patient CD4 cells counts at inclusion and at the end of the study period
CD4 countsa (cell/mm3) (median, IQR) [95% CI] | ||
|---|---|---|
At inclusion | At the end of the study period | |
Included patients (n = 10) | ||
Naïve patients (n = 3) | 280 (272–374) [272–374] | 524 (516–910) [516–910] |
Experienced patients (n = 7) | 654 (535–1167) [452–1170] | 828 (751–882) [473–1043] |
Patients who refused the program (n = 9) | ||
Experienced patients | 743 (682–970) [642–1011] | 836 (712–1031) [639–1232] |
Patients who were not invited to join the program (n = 22) | ||
Experienced patients | 697 (496–910) [496–910] | 685.5 (502–851) [502–851] |